High-Throughput Proteomic Profiling to Evaluate Differentiation Syndrome With Menin Inhibition
Miriam B. Garcia(The University of Texas MD Anderson Cancer Center), Hussein A. Abbas(The University of Texas MD Anderson Cancer Center), Georgina El Hajjar(The University of Texas MD Anderson Cancer Center), David McCall(The University of Texas MD Anderson Cancer Center), Irtiza Sheikh(The University of Texas MD Anderson Cancer Center), Branko Cuglievan(The University of Texas MD Anderson Cancer Center), Cesar Nunez(The University of Texas MD Anderson Cancer Center), Ghayas C. Issa(The University of Texas MD Anderson Cancer Center), Amber Gibson(The University of Texas MD Anderson Cancer Center), Bofei Wang(The University of Texas MD Anderson Cancer Center)
Cited by 0
Related Papers
Management guidelines for paediatric patients receiving chimeric antigen receptor T cell therapy
|Nature Reviews Clinical Oncology|2018|237
Venetoclax for Children and Adolescents with Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma
|Cancers|2021|66
Diagnosis, grading and management of toxicities from immunotherapies in children, adolescents and young adults with cancer
|Nature Reviews Clinical Oncology|2021|59
Classical Hodgkin Lymphoma: From Past to Future—A Comprehensive Review of Pathophysiology and Therapeutic Advances
|International Journal of Molecular Sciences|2023|54